# First Industrial Realty Trust Inc: financial statements, quarterly

FR · NYSE · CIK 921825 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fr.md) · [Financials](/companies/fr/financials.md) · [Filings](/companies/fr/filings.md) · [Insiders](/companies/fr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [155](/filings/0000921825-24-000096.md) | [157 d](/filings/0000921825-26-000012.md) | [162](/filings/0000921825-25-000039.md) | [164](/filings/0000921825-25-000074.md) | [168](/filings/0000921825-25-000107.md) | [176 d](/filings/0000921825-26-000012.md) | [177](/filings/0000921825-26-000054.md) | [180](/filings/0000921825-26-000068.md) | [181](/filings/0000921825-25-000107.md) | [188 d](/filings/0000921825-26-000012.md) | [195](/filings/0000921825-26-000054.md) | [195](/filings/0000921825-26-000068.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.3](/filings/0000921825-24-000096.md) | [0.7 d](/filings/0000921825-26-000012.md) | [1.2](/filings/0000921825-25-000039.md) | [0.4](/filings/0000921825-25-000074.md) | [3.3](/filings/0000921825-25-000107.md) | [1.2 d](/filings/0000921825-26-000012.md) | [5.9](/filings/0000921825-26-000054.md) | [0.1](/filings/0000921825-26-000068.md) | [0.2](/filings/0000921825-25-000107.md) | [9.1 d](/filings/0000921825-26-000012.md) | [4.0](/filings/0000921825-26-000054.md) | [(1.2)](/filings/0000921825-26-000068.md) |
| Net income | $m | [75.0](/filings/0000921825-24-000096.md) | [89.2 d](/filings/0000921825-26-000012.md) | [68.5](/filings/0000921825-25-000039.md) | [51.3](/filings/0000921825-25-000074.md) | [99.4](/filings/0000921825-25-000107.md) | [68.4 d](/filings/0000921825-26-000012.md) | [48.1](/filings/0000921825-26-000054.md) | [55.2](/filings/0000921825-26-000068.md) | [65.3](/filings/0000921825-25-000107.md) | [78.8 d](/filings/0000921825-26-000012.md) | [143](/filings/0000921825-26-000054.md) | [77.1](/filings/0000921825-26-000068.md) |
| Diluted EPS | $ per share | [0.57](/filings/0000921825-24-000096.md) | not reported | [0.52](/filings/0000921825-25-000039.md) | [0.39](/filings/0000921825-25-000074.md) | [0.75](/filings/0000921825-25-000107.md) | not reported | [0.36](/filings/0000921825-26-000054.md) | [0.42](/filings/0000921825-26-000068.md) | [0.49](/filings/0000921825-25-000107.md) | not reported | [1.08](/filings/0000921825-26-000054.md) | [0.58](/filings/0000921825-26-000068.md) |
| Basic EPS | $ per share | [0.57](/filings/0000921825-24-000096.md) | not reported | [0.52](/filings/0000921825-25-000039.md) | [0.39](/filings/0000921825-25-000074.md) | [0.75](/filings/0000921825-25-000107.md) | not reported | [0.36](/filings/0000921825-26-000054.md) | [0.42](/filings/0000921825-26-000068.md) | [0.49](/filings/0000921825-25-000107.md) | not reported | [1.08](/filings/0000921825-26-000054.md) | [0.58](/filings/0000921825-26-000068.md) |

- Revenue: us-gaap:Revenues
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [54.3](/filings/0000921825-23-000053.md) | [43.8](/filings/0000921825-25-000019.md) | [48.9](/filings/0000921825-24-000044.md) | [38.5](/filings/0000921825-24-000082.md) | [47.1](/filings/0000921825-24-000096.md) | [44.5](/filings/0000921825-26-000012.md) | [35.7](/filings/0000921825-25-000039.md) | [34.9](/filings/0000921825-25-000074.md) | [33.5](/filings/0000921825-25-000107.md) | [78.0](/filings/0000921825-26-000068.md) | [37.1](/filings/0000921825-26-000054.md) | [46.1](/filings/0000921825-26-000068.md) |
| Total assets | $m | [5,152](/filings/0000921825-23-000053.md) | [5,176](/filings/0000921825-25-000019.md) | [5,200](/filings/0000921825-24-000044.md) | [5,206](/filings/0000921825-24-000082.md) | [5,201](/filings/0000921825-24-000096.md) | [5,261](/filings/0000921825-26-000012.md) | [5,448](/filings/0000921825-25-000039.md) | [5,452](/filings/0000921825-25-000074.md) | [5,508](/filings/0000921825-25-000107.md) | [5,688](/filings/0000921825-26-000068.md) | [5,772](/filings/0000921825-26-000054.md) | [5,781](/filings/0000921825-26-000068.md) |
| Total liabilities | $m | [2,545](/filings/0000921825-23-000053.md) | [2,541](/filings/0000921825-25-000019.md) | [2,527](/filings/0000921825-24-000044.md) | [2,527](/filings/0000921825-24-000082.md) | [2,489](/filings/0000921825-24-000096.md) | [2,515](/filings/0000921825-26-000012.md) | [2,705](/filings/0000921825-25-000039.md) | [2,718](/filings/0000921825-25-000074.md) | [2,767](/filings/0000921825-25-000107.md) | [2,929](/filings/0000921825-26-000068.md) | [2,921](/filings/0000921825-26-000054.md) | [2,911](/filings/0000921825-26-000068.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [2,535](/filings/0000921825-23-000053.md) | [2,563](/filings/0000921825-25-000019.md) | [2,595](/filings/0000921825-24-000044.md) | [2,601](/filings/0000921825-24-000082.md) | [2,632](/filings/0000921825-24-000096.md) | [2,666](/filings/0000921825-26-000012.md) | [2,651](/filings/0000921825-25-000039.md) | [2,645](/filings/0000921825-25-000074.md) | [2,651](/filings/0000921825-25-000107.md) | [2,671](/filings/0000921825-26-000068.md) | [2,758](/filings/0000921825-26-000054.md) | [2,775](/filings/0000921825-26-000068.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [84.3 d](/filings/0000921825-24-000096.md) | [64.4 d](/filings/0000921825-26-000012.md) | [62.5](/filings/0000921825-25-000039.md) | [108 d](/filings/0000921825-25-000074.md) | [105 d](/filings/0000921825-25-000107.md) | [76.8 d](/filings/0000921825-26-000012.md) | [88.6](/filings/0000921825-26-000054.md) | [126 d](/filings/0000921825-26-000068.md) | [125 d](/filings/0000921825-25-000107.md) | [122 d](/filings/0000921825-26-000012.md) | [88.9](/filings/0000921825-26-000054.md) | [114 d](/filings/0000921825-26-000068.md) |
| Dividends paid | $m | [43.2 d](/filings/0000921825-24-000096.md) | [43.2 d](/filings/0000921825-26-000012.md) | [43.2](/filings/0000921825-25-000039.md) | [50.1 d](/filings/0000921825-25-000074.md) | [50.1 d](/filings/0000921825-25-000107.md) | [50.1 d](/filings/0000921825-26-000012.md) | [50.1](/filings/0000921825-26-000054.md) | [60.4 d](/filings/0000921825-26-000068.md) | [60.4 d](/filings/0000921825-25-000107.md) | [60.4 d](/filings/0000921825-26-000012.md) | [60.4](/filings/0000921825-26-000054.md) | [68.1 d](/filings/0000921825-26-000068.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [132](/filings/0000921825-23-000053.md) | [132](/filings/0000921825-24-000044.md) | [132](/filings/0000921825-24-000082.md) | [132](/filings/0000921825-24-000096.md) | [132](/filings/0000921825-25-000039.md) | [132](/filings/0000921825-25-000074.md) | [132](/filings/0000921825-25-000107.md) | [132](/filings/0000921825-26-000054.md) | [132](/filings/0000921825-26-000068.md) | [133](/filings/0000921825-25-000107.md) | [133](/filings/0000921825-26-000054.md) | [133](/filings/0000921825-26-000068.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 132,572,946 at 2026-07-23, from the cover of the [10-Q filed 2026-07-23](/filings/0000921825-26-000068.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.